Michael G. Atieh, Executive VP & CFO at OSI PHARMACEUTICALS INC (OSIP), sold 50,000 shares at $51.00 ($2.6M) on 2008-07-24, disclosed to the SEC on 2008-07-28.
Scheduled sale ($2.6M) by Executive VP & CFO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $51.00 | 23,753 | $1.2M | 47.5% |
| 2 | $51.01 | 5,254 | $268K | 10.5% |
| 3 | $51.02 | 600 | $31K | 1.2% |
| 4 | $51.03 | 1,400 | $71K | 2.8% |
| 5 | $51.04 | 1,800 | $92K | 3.6% |
| 6 | $51.05 | 1,621 |
| $83K |
| 3.2% |
| 7 | $51.06 | 100 | $5K | 0.2% |
| 8 | $51.07 | 800 | $41K | 1.6% |
| 9 | $51.08 | 600 | $31K | 1.2% |
| 10 | $51.09 | 1,421 | $73K | 2.8% |
| 11 | $51.10 | 3,272 | $167K | 6.6% |
| 12 | $51.11 | 900 | $46K | 1.8% |
| 13 | $51.12 | 5,200 | $266K | 10.4% |
| 14 | $51.13 | 479 | $24K | 1.0% |
| 15 | $51.16 | 1,468 | $75K | 2.9% |
| 16 | $51.17 | 200 | $10K | 0.4% |
| 17 | $51.18 | 1,000 | $51K | 2.0% |
| 18 | $51.20 | 32 | $2K | 0.1% |
| 19 | $51.22 | 100 | $5K | 0.2% |
| Total | $51.04 avg | 50,000 | $2.6M | 100% |
| Filing → |
| CB | SELL | 2024-09-05 | $150K | — | Filing → |
| CB | SELL | 2024-05-20 | $386K | — | Filing → |
| CB | SELL | 2023-08-14 | $313K | — | Filing → |